Everything about Healthcare News
Novo CEO pressed by Senate to cut costs of being overweight, diabetic issues medications CEO Lars Fruergaard Jørgensen told lawmakers the business would consider new talks with insurers in regards to the record selling prices of Wegovy and copyright should they pledge to help keep the medicines on their formularies.Never skip tomorrow's healthcare